Dr. Carl R. Thornfeldt is the CEO and Founder of Episciences, Inc. He is a practicing dermatologist with over 25 years of skin research experience, 22 U.S. patents granted and over 20 scientific publications in the area of treatment of skin diseases and conditions, including chapters in five dermatological textbooks. Along with these accomplishments, he has also spent nearly two decades focusing on researching the skin barrier and cutaneous inflammatory conditions.
“I know there are many compelling theories about skin. Through years of research and treating my patients, I found by repairing the barrier and blocking chronic inflammation had the most profound effect on aging and skin health in my patients. I have spent a lifetime on proving the safety and efficacy of our product.
As a physician, I knew my peers would want evidence and in my practice, I use prescription products to clear conditions, but then I use Epionce products to block inflammation and rebuild the skin barrier in order to maintain a longer remission period.”
Dr. Thornfeldt received his M.D. from the Oregon Health Sciences University. Soon after, he spent three years in family practice for the U.S. Navy, and completed his dermatology residency at University Hospital, San Diego, California. While running his private practice and conducting research, Dr. Thornfeldt has co-founded and held the position of CEO at several privately and publicly held companies.
Dr. Thornfeldt presents at international, national and regional scientific meetings including the Chinese Academy of Dermatology, THE Aesthetic Show, the American Society for Laser Medicine and Surgery, the National Society of Cosmetic Physicians, the American Society of Dermatologic Surgery and the Facial Aesthetics Conference and Expo in London. In the winter of 2010 his first full-length textbook was released.
In 2003 and 2005, Dr. Thornfeldt was selected as one of the top 50 doctors in the U.S. by The Sinatra Health Report. He was the only dermatologist on the list.